1887
  1. Home
  2. Eurosurveillance
  3. Volume 30, Issue 38, 25/Sep/2025
  4. Article
Perspective Open Access
Like 0
Download

Abstract

Two rotavirus strain surveillance networks operate in Europe: the World Health Organization Global Rotavirus Surveillance Network and the European Rotavirus Network (EuroRotaNet). We describe and appraise rotavirus strain surveillance, with a focus on EuroRotaNet, which has conducted rotavirus strain surveillance since 2007 across 21 European countries. Since EuroRotaNet began, epidemiological and genotype data has been collected on over 90,000 rotavirus-positive specimens. We identified distinct differences in strain distribution across seasons, countries, regions and age cohorts. As infant rotavirus vaccination has been rolled out in some European countries, the EuroRotaNet surveillance network is able to monitor changes in strain type circulation and signs of potential emergence of vaccine escape strains, comparing countries with and without vaccination programs. Despite natural fluctuations in strain distribution, the data show an increase in strain diversity after vaccine introduction, although no strain displacement due to vaccination nor emergence of unusual strains of epidemiologically significance were noted. The EuroRotaNet surveillance network takes a pragmatic approach to surveillance and is not overly prescriptive, creating a wide, engaged and sustainable network.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.38.2400798
2025-09-25
2026-04-18
/content/10.2807/1560-7917.ES.2025.30.38.2400798
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/38/eurosurv-30-38-3.html?itemId=/content/10.2807/1560-7917.ES.2025.30.38.2400798&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). Rotavirus. Geneva: WHO. [Accessed: 19 Jun 2022]. Available from: https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/norms-and-standards/vaccines-quality/rotavirus
  2. Bergman H, Henschke N, Hungerford D, Pitan F, Ndwandwe D, Cunliffe N, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2021;11(11):CD008521. PMID: 34788488 
  3. Matthijnssens J, Otto PH, Ciarlet M, Desselberger U, Van Ranst M, Johne R. VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation. Arch Virol. 2012;157(6):1177-82.  https://doi.org/10.1007/s00705-012-1273-3  PMID: 22430951 
  4. Matthijnssens J, Ciarlet M, Rahman M, Attoui H, Bányai K, Estes MK, et al. Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol. 2008;153(8):1621-9.  https://doi.org/10.1007/s00705-008-0155-1  PMID: 18604469 
  5. World Health Organization (WHO). Meeting of the immunization Strategic Advisory Group of Experts, April 2009--conclusions and recommendations. Wkly Epidemiol Rec. 2009;84(23):220-36. PMID: 19499606 
  6. World Health Organization (WHO). Meeting of the Strategic Advisory Group of Experts on Immunization, October 2020 – conclusions and recommendations. Weekly Epidemiological Record. 2020;95(‎48)‎:585–607. Available from: https://apps.who.int/iris/handle/10665/337109
  7. Hungerford D, Vivancos R, Read JM, Iturriza-Gόmara M, French N, Cunliffe NA. Rotavirus vaccine impact and socioeconomic deprivation: an interrupted time-series analysis of gastrointestinal disease outcomes across primary and secondary care in the UK. BMC Med. 2018;16(1):10.  https://doi.org/10.1186/s12916-017-0989-z  PMID: 29375036 
  8. Black RE, Perin J, Yeung D, Rajeev T, Miller J, Elwood SE, et al. Estimated global and regional causes of deaths from diarrhoea in children younger than 5 years during 2000-21: a systematic review and Bayesian multinomial analysis. Lancet Glob Health. 2024;12(6):e919-28.  https://doi.org/10.1016/S2214-109X(24)00078-0  PMID: 38648812 
  9. Cohen R, Martinón-Torres F, Posiuniene I, Benninghoff B, Oh KB, Poelaert D. The value of rotavirus vaccination in Europe: A call for action. Infect Dis Ther. 2023;12(1):9-29.  https://doi.org/10.1007/s40121-022-00697-7  PMID: 36355309 
  10. European Centre for Disease Prevention and Control (ECDC). Vaccine schedule: Recommended immunisations for rotavirus infection. Stockholm: ECDC. [Accessed: 2 May 2025]. Available from: http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx
  11. Haute Autorité de Santé (HAS). Recommandation vaccinale contre les infections à rotavirus - Révision de la stratégie vaccinale et détermination de la place des vaccins Rotarix et RotaTeq. [Vaccination recommendation against rotavirus infections - Review of the vaccination strategy and determination of the role of Rotarix and RotaTeq vaccines]. Saint-Denis La Plaine: HAS; 2022. French. Available from: https://www.has-sante.fr/jcms/p_3321070/fr/recommandation-vaccinale-contre-les-infections-a-rotavirus-revision-de-la-strategie-vaccinale-et-determination-de-la-place-des-vaccins-rotarix-et-rotateq
  12. Ianiro G, Heylen E, Delogu R, Zeller M, Matthijnssens J, Ruggeri FM, et al. Genetic diversity of G9P[8] rotavirus strains circulating in Italy in 2007 and 2010 as determined by whole genome sequencing. Infect Genet Evol. 2013;16:426-32.  https://doi.org/10.1016/j.meegid.2013.03.031  PMID: 23542095 
  13. Giammanco GM, Bonura F, Zeller M, Heylen E, Van Ranst M, Martella V, et al. Evolution of DS-1-like human G2P[4] rotaviruses assessed by complete genome analyses. J Gen Virol. 2014;95(Pt 1):91-109.  https://doi.org/10.1099/vir.0.056788-0  PMID: 24077298 
  14. Desselberger U, Huppertz HI. Immune responses to rotavirus infection and vaccination and associated correlates of protection. J Infect Dis. 2011;203(2):188-95.  https://doi.org/10.1093/infdis/jiq031  PMID: 21288818 
  15. Pitzer VE, Patel MM, Lopman BA, Viboud C, Parashar UD, Grenfell BT. Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions. Proc Natl Acad Sci USA. 2011;108(48):19353-8.  https://doi.org/10.1073/pnas.1110507108  PMID: 22084114 
  16. Iturriza-Gómara M, Dallman T, Bányai K, Böttiger B, Buesa J, Diedrich S, et al. Rotavirus surveillance in europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data. J Infect Dis. 2009;200(s1) Suppl 1;S215-21.  https://doi.org/10.1086/605049  PMID: 19821712 
  17. Hungerford D, Allen DJ, Nawaz S, Collins S, Ladhani S, Vivancos R, et al. Impact of rotavirus vaccination on rotavirus genotype distribution and diversity in England, September 2006 to August 2016. Euro Surveill. 2019;24(6):1700774.  https://doi.org/10.2807/1560-7917.ES.2019.24.6.1700774  PMID: 30755297 
  18. Hungerford D, EuroRotaNet network members. EuroRotaNet Annual Report 2021. Liverpool: University of Liverpool; 2023 p. 1-32. Available from: https://www.eurorotanet.com/wp-content/uploads/2023/03/EuroRotaNet_report-2021_20220303_Final-v1.0.pdf
  19. Hungerford D, Vivancos R, Read JM, Pitzer VE, Cunliffe N, French N, et al. In-season and out-of-season variation of rotavirus genotype distribution and age of infection across 12 European countries before the introduction of routine vaccination, 2007/08 to 2012/13. Euro Surveill. 2016;21(2).  https://doi.org/10.2807/1560-7917.ES.2016.21.2.30106  PMID: 26794258 
  20. Hungerford D, EuroRotaNet network members. EuroRotaNet Annual Report Season 2022/23. Liverpool: University of Liverpool; Mar 2025. p. 1-32. Available from: https://www.eurorotanet.com/wp-content/uploads/2025/04/EuroRotaNet_report-2023_20250331_final_v1.0.pdf
  21. Zeller M, Rahman M, Heylen E, De Coster S, De Vos S, Arijs I, et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine. 2010;28(47):7507-13.  https://doi.org/10.1016/j.vaccine.2010.09.004  PMID: 20851085 
  22. Mhango C, Mandolo JJ, Chinyama E, Wachepa R, Kanjerwa O, Malamba-Banda C, et al. Rotavirus genotypes in hospitalized children with acute gastroenteritis before and after rotavirus vaccine introduction in Blantyre, Malawi, 1997-2019. J Infect Dis. 2022;225(12):2127-36.  https://doi.org/10.1093/infdis/jiaa616  PMID: 33033832 
  23. Gurgel RQ, Cuevas LE, Vieira SCF, Barros VCF, Fontes PB, Salustino EF, et al. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis. 2007;13(10):1571-3.  https://doi.org/10.3201/eid1310.070412  PMID: 18258011 
  24. Cates JE, Amin AB, Tate JE, Lopman B, Parashar U. Do rotavirus strains affect vaccine effectiveness? A systematic review and meta-analysis. Pediatr Infect Dis J. 2021;40(12):1135-43.  https://doi.org/10.1097/INF.0000000000003286  PMID: 34870393 
  25. Amin AB, Cates JE, Liu Z, Wu J, Ali I, Rodriguez A, et al. Rotavirus genotypes in the postvaccine era: a systematic review and meta-analysis of global, regional, and temporal trends by rotavirus vaccine introduction. J Infect Dis. 2024;229(5):1460-9.  https://doi.org/10.1093/infdis/jiad403  PMID: 37738554 
  26. Koukou DM, Michos A, Chatzichristou P, Trimis G, Tatsi EB, Dellis C, et al. Rotavirus epidemiology and genotype distribution in hospitalised children, Greece, 2008 to 2020: A prospective multicentre study. Euro Surveill. 2022;27(47):2101133.  https://doi.org/10.2807/1560-7917.ES.2022.27.47.2101133  PMID: 36695456 
  27. Simsek C, Bloemen M, Jansen D, Descheemaeker P, Reynders M, Van Ranst M, et al. Rotavirus vaccine-derived cases in Belgium: Evidence for reversion of attenuating mutations and alternative causes of gastroenteritis. Vaccine. 2022;40(35):5114-25.  https://doi.org/10.1016/j.vaccine.2022.06.082  PMID: 35871871 
  28. Hsieh YC, Wu FT, Hsiung CA, Wu HS, Chang KY, Huang YC. Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine. Vaccine. 2014;32(10):1199-204.  https://doi.org/10.1016/j.vaccine.2013.08.041  PMID: 24076325 
  29. Iturriza-Gómara M, Dallman T, Bányai K, Böttiger B, Buesa J, Diedrich S, et al. Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network. Epidemiol Infect. 2011;139(6):895-909.  https://doi.org/10.1017/S0950268810001810  PMID: 20707941 
  30. Love NK, Elliot AJ, Chalmers RM, Douglas A, Gharbia S, McCormick J, et al. Impact of the COVID-19 pandemic on gastrointestinal infection trends in England, February-July 2020. BMJ Open. 2022;12(3):e050469.  https://doi.org/10.1136/bmjopen-2021-050469  PMID: 35314468 
  31. UK Health Security Agency. National norovirus and rotavirus report, week 12 report: data up to week 10 (12 March 2023). London: GOV.UK. [Accessed: 2 Oct 2023]. Available from: https://www.gov.uk/government/statistics/national-norovirus-and-rotavirus-surveillance-reports-2022-to-2023-season/national-norovirus-and-rotavirus-report-week-12-report-data-up-to-week-10-12-march-2023
  32. Centers for Disease Control and Prevention (CDC). WHO Global Rotavirus Surveillance Network: A strategic review of the first 5 years, 2008-2012. Atlanta: CDC; 25 Jul 2014. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6329a5.htm
  33. European Centre for Disease Prevention and Control (ECDC). Expert opinion on rotavirus vaccination in infancy. Stockholm: ECDC; 2018. Available from: https://data.europa.eu/doi/10.2900/362947
  34. Verkerk JDM, Bruijning-Verhagen P, de Melker H. Rotavirus in the Netherlands: Background information for the Health Council. Bilthoven: National Institute for Public Health and the Environment; 2017. Available from: http://hdl.handle.net/10029/620838
  35. International Vaccine Access Center (IVAC). Johns Hopkins Bloomberg School of Public Health. VIEW-hub. Baltimore: IVAC. [Accessed: 7 May 2025]. Available from: www.view-hub.org
  36. European Centre for Disease Prevention and Control (ECDC). Vaccine scheduler. Stockholm: ECDC. [Accessed: 2 May 2025]. Available from: https://vaccine-schedule.ecdc.europa.eu/Scheduler
Contribution of the EuroRotaNet surveillance network to rotavirus strain surveillance in Europe
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Natasha+Marcella+Vaselli&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vaselli Natasha Marcella</a>, <a href="/search?value1=Miren+Iturriza-G%C3%B3mara&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Iturriza-Gómara Miren</a>, <a href="/search?value1=Daniel+Hungerford&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hungerford Daniel</a>, <a href="/search?value1=EuroRotaNet+network+members&option1=author&noRedirect=true" class="nonDisambigAuthorLink">EuroRotaNet network members</a></span>. Contribution of the EuroRotaNet surveillance network to rotavirus strain surveillance in Europe. <a href="/content/ecdc">Euro Surveill.</a> 2025;30(38):pii=2400798. <a href="https://doi.org/10.2807/1560-7917.ES.2025.30.38.2400798" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2025.30.38.2400798</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 02 Dec 2024;&nbsp;&nbsp; <span class="generated">Accepted</span>: 13 May 2025 </span> </p>
/content/10.2807/1560-7917.ES.2025.30.38.2400798
/content/10.2807/1560-7917.ES.2025.30.38.2400798
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error